|

JAB-23E73 Clinical Trials

2 actively recruiting trials across 1 location

Other1 trial

A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration
Phase 1/2

Rochester, Minnesota1 trial

JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration

Mayo Clinic

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.